Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-24 @ 6:49 PM
Study NCT ID:
NCT00420420
Status:
COMPLETED
Last Update Posted:
2015-02-12
First Post:
2007-01-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-09
First Submit QC Date:
None
Study First Post Date:
2007-01-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-10-25
Results First Submit QC Date:
None
Results First Post Date:
2010-11-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-28
Last Update Post Date:
2015-02-12
Last Update Post Date Type:
ESTIMATED